CO4940495A1 - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number
CO4940495A1
CO4940495A1 CO98037137A CO98037137A CO4940495A1 CO 4940495 A1 CO4940495 A1 CO 4940495A1 CO 98037137 A CO98037137 A CO 98037137A CO 98037137 A CO98037137 A CO 98037137A CO 4940495 A1 CO4940495 A1 CO 4940495A1
Authority
CO
Colombia
Prior art keywords
matter
composition
sertraline
solubilizing agent
compositions
Prior art date
Application number
CO98037137A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Friesen Dwayne
Scott Max Herbig
Ravi Wysore Shanker
West James Blair
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940495(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO4940495A1 publication Critical patent/CO4940495A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CO98037137A 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina CO4940495A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
CO4940495A1 true CO4940495A1 (es) 2000-07-24

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98037137A CO4940495A1 (es) 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (id)
JP (1) JP2000514100A (id)
KR (1) KR100366373B1 (id)
CN (1) CN1261794A (id)
AP (1) AP1192A (id)
AR (3) AR015917A1 (id)
AU (1) AU742535B2 (id)
BG (1) BG103918A (id)
BR (1) BR9810739A (id)
CA (1) CA2290974C (id)
CO (1) CO4940495A1 (id)
DZ (1) DZ2548A1 (id)
EA (1) EA002481B1 (id)
HN (1) HN1998000102A (id)
HR (1) HRP980377A2 (id)
HU (1) HUP0002236A3 (id)
ID (1) ID23429A (id)
IL (1) IL133076A (id)
IS (1) IS5260A (id)
MA (1) MA24587A1 (id)
NO (1) NO996520L (id)
OA (1) OA11243A (id)
PA (1) PA8454301A1 (id)
PE (1) PE97199A1 (id)
PL (1) PL337804A1 (id)
SK (1) SK181099A3 (id)
TN (1) TNSN98124A1 (id)
TR (1) TR199903297T2 (id)
TW (1) TW550087B (id)
UA (1) UA67741C2 (id)
UY (1) UY25071A1 (id)
WO (1) WO1999001120A1 (id)
YU (1) YU68299A (id)
ZA (1) ZA985708B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DK0415612T3 (da) * 1989-08-30 1993-12-13 Pfizer Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (en) 2000-07-31
AU742535B2 (en) 2002-01-03
IL133076A (en) 2003-12-10
IS5260A (is) 1999-11-19
CN1261794A (zh) 2000-08-02
CA2290974C (en) 2004-04-27
HUP0002236A3 (en) 2003-12-29
KR100366373B1 (ko) 2003-01-14
JP2000514100A (ja) 2000-10-24
DZ2548A1 (fr) 2003-02-08
ID23429A (id) 2000-04-20
TNSN98124A1 (fr) 2005-03-15
HUP0002236A2 (hu) 2003-08-28
EA199900962A1 (ru) 2000-08-28
PE97199A1 (es) 1999-10-05
CA2290974A1 (en) 1999-01-14
SK181099A3 (en) 2000-07-11
NO996520D0 (no) 1999-12-28
EP0999829A1 (en) 2000-05-17
PA8454301A1 (es) 2000-09-29
AP9801280A0 (en) 1998-06-30
MA24587A1 (fr) 1998-12-31
AR015917A1 (es) 2001-05-30
AR040279A2 (es) 2005-03-23
HN1998000102A (es) 1999-01-08
KR20010013365A (ko) 2001-02-26
UA67741C2 (uk) 2004-07-15
ZA985708B (en) 2000-01-10
AU7544898A (en) 1999-01-25
UY25071A1 (es) 2000-12-29
YU68299A (sh) 2002-06-19
EA002481B1 (ru) 2002-06-27
AP1192A (en) 2003-07-23
TR199903297T2 (xx) 2000-07-21
WO1999001120A1 (en) 1999-01-14
OA11243A (en) 2003-07-24
AR040280A2 (es) 2005-03-23
HRP980377A2 (en) 1999-04-30
NO996520L (no) 2000-02-29
BR9810739A (pt) 2000-09-12
TW550087B (en) 2003-09-01
PL337804A1 (en) 2000-09-11
IL133076A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
EA199801086A1 (ru) Неводные медицинские средства для очистки толстой кишки
AR018211A1 (es) Composiciones de glifosfato acuoso altamente concentrado
EA199900749A1 (ru) Фармацевтическая композиция
AR010579A1 (es) Composicion de limpieza y desinfeccion acuosa lista para usar y proceso para desinfeccion de superficies duras.
KR940013538A (ko) 자기공명 조영 강화제인 수불용성 망간입자
ES2014309T5 (es) Utilizacion de una sal para influenciar el vertido de composiciones espesas.
ES2155425T1 (es) Concentrado de revelador de color fotografico de un solo envase y homogeneo, y metodo para prepararlo.
ES2189466T3 (es) Formulacion de glifosato.
ES527150A0 (es) Un procedimiento para la preparacion de una solucion desinfectante acuosa de peroxido de hidrogeno.
CO5320593A1 (es) Composiciones herbicidas
CO4940495A1 (es) Composiciones solubilizadas de sertralina
ES2179103T3 (es) Composicion detergente.
KR940005498A (ko) 인공 해수
KR890004765A (ko) 화장품 제제에서 사용하기 위한 증점된 수성 계면 활성제 용액
MY130555A (en) Super absorbent polymer composition
ES2038034T3 (es) Composicion acuosa tampon gelificable y su utilizacion para la recuperacion mejorada de petroleo.
JPS5375331A (en) Exterminating agent for noxious aquatic life
KR970706732A (ko) 엘레우테로빈 및 그의 유사체(ELEUTHEROBlN AND ANALOGS THEREOF)
PE22995A1 (es) Composicion de tiotepa liofilizada estable
KR930019808A (ko) 세정제 조성물
KR920014474A (ko) 담석 붕괴용 제제
Roy Impact of detergents on the protein histochemistry of various cell types of the gill epithelium of Rita rita
ATE368468T1 (de) Ionische wässrige lösungen und deren verwendungen insbesondere in der ophtalmologie
ES2168113T3 (es) Disolucion blanqueadora de lactona/peroxido, sistema blanqueador para formar la misma y metodo de preparacion y uso de la misma.
FR2843029B1 (fr) Solution de rincage pour lentilles de contact